BSE Test Under Assessment

23 June 1996

- A test developed by the Institute for Animal Science and Health, for the early detection of BSE and CJD, is under assessment by the UK Veterinary Laboratories Agency. Using scrapie as a model, the researchers reported in Nature (June 13) that they have developed antibodies which bind to the abnormal prion responsible for the diseases. This test was used on a tonsil biopsy of a 10-month-old sheep, detecting the disease in less than half the normal incubation time. Present diagnosis relies on post-mortem studies of brain tissue.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight